Filter Results:
(700)
Show Results For
- All HBS Web
(700)
- News (83)
- Research (529)
- Events (3)
- Multimedia (8)
- Faculty Publications (454)
Show Results For
- All HBS Web
(700)
- News (83)
- Research (529)
- Events (3)
- Multimedia (8)
- Faculty Publications (454)
- January 1980 (Revised September 1988)
- Case
Germany (A): The Rebirth of an Economy
Anderson, Douglas D. "Germany (A): The Rebirth of an Economy." Harvard Business School Case 380-120, January 1980. (Revised September 1988.)
- August 2022
- Article
Availability of New Medicines in the U.S. and Germany From 2004 to 2018
By: Katharina Blankart, Huseyin Naci and Amitabh Chandra
Importance: Germany's unique approach to coverage determination and pricing has ensured that effective medicines remain on the market, often at prices reduced through negotiation. However, less is known about trade-offs of this approach with regard to initial... View Details
Keywords: Market Entry and Exit; Price; Market Timing; Governing Rules, Regulations, and Reforms; Pharmaceutical Industry; United States; Germany
Blankart, Katharina, Huseyin Naci, and Amitabh Chandra. "Availability of New Medicines in the U.S. and Germany From 2004 to 2018." e2229231. JAMA Network Open 5, no. 8 (August 2022).
- 1992
- Article
British Business in Germany since the Nineteenth Century
By: G. Jones
Keywords: Business Ventures; Business History; Cross-Cultural and Cross-Border Issues; Germany; United Kingdom
Jones, G. "British Business in Germany since the Nineteenth Century." Zeitschrift für Unternehmensgeschichte 37 (1992).
- 2024
- Working Paper
Scared Straight? Threat and Assimilation of Refugees in Germany
By: Philipp Jaschke, Sulin Sardoschau and Marco Tabellini
This paper examines the impact of local hostility on the assimilation of refugees. We leverage plausibly exogenous variation in refugees' allocation across German regions between 2013 and 2016, and combine representative survey data and administrative records with... View Details
Keywords: Assimilation; Threat Hypothesis; Migration; Cultural Change; Refugees; Culture; Identity; Germany
Jaschke, Philipp, Sulin Sardoschau, and Marco Tabellini. "Scared Straight? Threat and Assimilation of Refugees in Germany." Harvard Business School Working Paper, No. 22-043, December 2021. (Revised August 2024. Also available from NBER, and featured on Le Monde.)
- 2004
- Book
Pharmacopolitics: Drug Regulation in the United States and Germany
By: Arthur A. Daemmrich
Keywords: Health; Governing Rules, Regulations, and Reforms; Government and Politics; United States; Germany
Daemmrich, Arthur A. Pharmacopolitics: Drug Regulation in the United States and Germany. University of North Carolina Press, 2004. (Winner of Edward Kremers Award of the American Institute of the History of Pharmacy For best book in pharmaco-historical writing published in the previous two years presented by American Institute of the History of Pharmacy.)
- 11 Sep 2019
- Research & Ideas
Germany May Have the Answer for Reducing Drug Prices
American lawmakers attempting to stem spiraling drug costs might find inspiration in Germany, where the government’s regulatory model has been curbing price growth without thwarting innovation or access, says research from Harvard Business School. Since 2011, View Details
- 09 Sep 2015
- News
Here's why Germany is welcoming migrants with open arms
- February 1993 (Revised April 1993)
- Teaching Note
Germany in the 1990s: Managing Reunification and Supplement TN
By: George C. Lodge
Teaching Note for (9-793-033) and (9-793-042). View Details
- January 2006 (Revised April 2006)
- Supplement
Dr. Ing. h.c. F. Porsche AG (B): Made in Germany
By: Jeffrey Fear and Carin-Isabel Knoop
Fear, Jeffrey, and Carin-Isabel Knoop. "Dr. Ing. h.c. F. Porsche AG (B): Made in Germany." Harvard Business School Supplement 706-019, January 2006. (Revised April 2006.)
- May 1980 (Revised July 1980)
- Case
Germany (B): The Uncertain Stride of a Reluctant Giant
Anderson, Douglas D. "Germany (B): The Uncertain Stride of a Reluctant Giant." Harvard Business School Case 380-121, May 1980. (Revised July 1980.)
- 19 Jul 2019
- News
Can Germany help the U.S. lower prescription drug prices?
- March 1996
- Case
Germany and the Bonn-Berlin Split: Supporting Distributed Work Through IT
By: Lynda M. Applegate and Carin-Isabel Knoop
Applegate, Lynda M., and Carin-Isabel Knoop. "Germany and the Bonn-Berlin Split: Supporting Distributed Work Through IT." Harvard Business School Case 396-169, March 1996.
- 2022
- Book
Empires of Ideas: Creating the Modern University from Germany to America to China
By: William C. Kirby
The modern university was born in Germany. In the twentieth century, the United States leapfrogged Germany to become the global leader in higher education. Will China challenge its position in the twenty-first?
Today American institutions dominate nearly every... View Details
Today American institutions dominate nearly every... View Details
Kirby, William C. Empires of Ideas: Creating the Modern University from Germany to America to China. Cambridge, MA: Belknap Press of Harvard University Press, 2022.
- 08 Jul 2019
- News
What the U.S. can learn from Germany on drug prices
- 2003
- Chapter
Regulatory Laws and Political Culture in the United States and Germany
By: Arthur A. Daemmrich
- October 1991 (Revised December 1992)
- Background Note
Note on Corporate Governance Systems: The United States, Japan, and Germany
By: W. Carl Kester and Robert W. Lightfoot
Describes and compares the corporate governance systems commonly found in the United States, Japan, and Germany. View Details
Kester, W. Carl, and Robert W. Lightfoot. "Note on Corporate Governance Systems: The United States, Japan, and Germany." Harvard Business School Background Note 292-012, October 1991. (Revised December 1992.)
- July 2020
- Article
Lessons from the Impact of Price Regulation on the Pricing of Anticancer Drugs in Germany
By: Victoria D. Lauenroth, Aaron S. Kesselheim, Ameet Sarpatwari and Ariel Dora Stern
Worldwide spending on prescription drugs has increased dramatically in recent years. Although this increase has been particularly pronounced in the U.S., it remains largely unaddressed there. In Europe, however, different approaches to regulating drug prices have been... View Details
Keywords: Pharmaceuticals; Prescription Drug Costs; Drug Pricing; Access To Care; Cost Reduction; Health Care and Treatment; Price; Governing Rules, Regulations, and Reforms; Cost Management; Germany
Lauenroth, Victoria D., Aaron S. Kesselheim, Ameet Sarpatwari, and Ariel Dora Stern. "Lessons from the Impact of Price Regulation on the Pricing of Anticancer Drugs in Germany." Health Affairs 39, no. 7 (July 2020): 1185–1193.
- 2006
- Book
Consumer Capitalism: Politics, Product Markets, and Firm Strategy in France and Germany
By: Gunnar Trumbull
Trumbull, Gunnar. Consumer Capitalism: Politics, Product Markets, and Firm Strategy in France and Germany. Ithaca: Cornell University Press, 2006.
- April 1993
- Teaching Note
Note on Corporate Governance Systems: The United States, Japan, and Germany (TN)
By: W. Carl Kester
Teaching Note for (9-292-012). View Details